MXCT vs LNTH vs RMD vs BTBT vs MDT

For growth investors, Bit Digital, Inc.

(BTBT) is the stronger pick with 264. 6% revenue growth year-over-year, versus -14. 5% for MaxCyte, Inc. (MXCT). Bit Digital, Inc. (BTBT) offers the better valuation at 9. 0x trailing P/E, making it the more compelling value choice. Analysts rate Lantheus Holdings, Inc. (LNTH) a "Buy" — based on 17 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.

On trailing P/E, Bit Digital, Inc.

(BTBT) is the cheapest at 9. 0x versus Lantheus Holdings, Inc. at 27. 3x. On forward P/E, Medtronic plc is actually cheaper at 13. 8x — notably different from the trailing picture, reflecting expected earnings growth. The PEG ratio (P/E divided by earnings growth rate) is the most growth-adjusted single valuation metric: ResMed Inc. wins at 1. 07x versus Medtronic plc's 35. 17x — a reasonable growth-adjusted valuation.

Over the past 5 years, Lantheus Holdings, Inc.

(LNTH) delivered a total return of +338. 1%, compared to -95. 0% for MaxCyte, Inc. (MXCT). Over 10 years, the gap is even starker: LNTH returned +42. 9% versus MXCT's -95. 0%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.

By beta (market sensitivity over 5 years), Medtronic plc (MDT) is the lower-risk stock at 0.

42β versus Bit Digital, Inc. 's 3. 41β — meaning BTBT is approximately 705% more volatile than MDT relative to the S&P 500. On balance sheet safety, Lantheus Holdings, Inc. (LNTH) carries a lower debt/equity ratio of 0% versus 59% for Medtronic plc — giving it more financial flexibility in a downturn.

By revenue growth (latest reported year), Bit Digital, Inc.

(BTBT) is pulling ahead at 264. 6% versus -14. 5% for MaxCyte, Inc. (MXCT). On earnings-per-share growth, the picture is similar: Bit Digital, Inc. grew EPS 225. 0% year-over-year, compared to -21. 8% for Lantheus Holdings, Inc.. Over a 3-year CAGR, LNTH leads at 18. 1% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.

ResMed Inc.

(RMD) is the more profitable company, earning 27. 2% net margin versus -135. 1% for MaxCyte, Inc. — meaning it keeps 27. 2% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: RMD leads at 32. 7% versus -138. 3% for MXCT. At the gross margin level — before operating expenses — MXCT leads at 81. 2%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.

The PEG ratio (forward P/E divided by expected earnings growth rate) is the most precise measure of undervaluation relative to growth potential.

By this metric, ResMed Inc. (RMD) is the more undervalued stock at a PEG of 1. 07x versus Medtronic plc's 35. 17x. A PEG below 1. 5 suggests fair-to-attractive pricing relative to expected growth. On forward earnings alone, Medtronic plc (MDT) trades at 13. 8x forward P/E versus 18. 6x for ResMed Inc. — 4. 8x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for BTBT: 177. 8% to $5. 00.

In this comparison, MDT (3.

7% yield), RMD (1. 0% yield), BTBT (0. 3% yield) pay a dividend. MXCT, LNTH do not pay a meaningful dividend and should not be held primarily for income.

For long-horizon retirement investors, Medtronic plc (MDT) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0.

42), 3. 7% yield). Bit Digital, Inc. (BTBT) carries a higher beta of 3. 41 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (MDT: +24. 3%, BTBT: -61. 0%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.

These companies operate in different sectors (MXCT (Healthcare) and LNTH (Healthcare) and RMD (Healthcare) and BTBT (Financial Services) and MDT (Healthcare)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.

In terms of investment character: MXCT is a small-cap quality compounder stock; LNTH is a small-cap quality compounder stock; RMD is a mid-cap quality compounder stock; BTBT is a small-cap high-growth stock; MDT is a mid-cap income-oriented stock. RMD, MDT pay a dividend while MXCT, LNTH, BTBT do not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.